Journal article
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.
Abstract
OBJECTIVE: To use protein biomarkers to identify people with type 2 diabetes at high risk of cardiovascular outcomes and death.
RESEARCH DESIGN AND METHODS: Biobanked serum from 4,957 ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) trial participants was analyzed. Forward-selection Cox models identified independent protein risk factors for major adverse cardiovascular events (MACE) and death that were compared with a previously …
Authors
Gerstein HC; Hess S; Claggett B; Dickstein K; Kober L; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Tardif J-C
Journal
Diabetes Care, Vol. 45, No. 9, pp. 2152–2155
Publisher
American Diabetes Association
Publication Date
September 1, 2022
DOI
10.2337/dc22-0453
ISSN
0149-5992